Collaborating to Develop the Most Effective Education Programs

We are working on many global and local initiatives designed to inspire and inform our patients, healthcare professionals (HCPs), payers and decision makers. But we go further, joining forces to support people developing educational programs around the world to improve the management of diabetes.   

Education contributes to the value we bring to patients and their care givers and is integral to Sanofi’s commitment to empowering our customers’ lives. 

For example, KiDS and Diabetes in School is a project in partnership with IDF (International Diabetes Federation) and ISPAD (International Society for Pediatric and Adolescent Diabetes). An educational program targeting teachers, school nurses and other staff, schoolchildren (6–14 years old) and their parents, the program aims to foster a safe, supportive environment in schools for children with diabetes, encouraging the adoption of good, healthy habits from an early age. Since its launch, KiDS has been implemented in 175 schools globally, including in Brazil, Egypt, India, Japan, Pakistan, Poland, United Arab Emirates, and Hungary, and has educated 60,000 children and 8,000 teachers and school staff.   

IDMPS: The IDMPS is the largest observational study of adult diabetes care in emerging countries. Involving 81,500 people, 6,000 HCPs and 50 countries, through IDMPS we have learned that diabetes education has a positive impact on people with type 2 diabetes. Diabetes-related complications were reduced and engagement with treatment was better. The many small but significant improvements in people who receive diabetes-specific education could contribute to better outcomes. Therefore, we believe that diabetes education should be part of an overall program of care. 

E-diabete:  An educational program about diabetes transmitted via low-speed internet and conducted in partnership with UNFM, RAFT and Senghor University. 14 Africa countries are now connected to the network (including Senegal, Cote d'Ivoire, Cameroon, Mali, Congo, Madagascar, etc). Since the beginning of e-diabete, 92 training sessions have taken place, reaching more than 22,500 HCPs.   

Every1matters: The T1D Challenge's adventure started in November 2012 when Sanofi began to highlight that diabetes doesn’t limit people or impose limitations upon them. This sports challenge with type 1 diabetics from around the world has proven that people living with diabetes do not need to be afraid to live their lives and passions to the fullest, despite the disease.

Related Articles


We work tirelessly to develop a broad range of innovative medicines, from oral treatments and insulins to combination therapies

Integrated Solutions

Integrated solutions that connect treatments, services and data analytics to enable people to live the life they want

Access to Healthcare

Partnerships with health authorities and payers to provide as many people as possible with the best  access to healthcare